Posts by: Forest Ray PhD

Forest Ray PhD

Forest Ray received his PhD in systems biology from Columbia University, where he developed tools to match drug side effects to other diseases. He has since worked as a journalist and science writer, covering topics from rare diseases to the intersection between environmental science and social justice. He currently lives in Long Beach, California.

March 4, 2021March 4, 2021

Actemra Injections for sJIA, pJIA Easier Than Comparable Infusions

News

Compared with an infusion into the vein, injecting Actemra (tocilizumab) under the skin offers people with systemic and polyarticular juvenile idiopathic arthritis (JIA) similar performance in a more convenient route ... Read more

February 25, 2021February 25, 2021

UK Group Awarded £600K to Study Juvenile Arthritis, Related Disorders

News

Versus Arthritis has funded three more years of research into therapies for juvenile arthritis and related conditions at the U.K. Experimental Arthritis Treatment Centre for Children (EATC4Children) with a £600,000 ... Read more

January 28, 2021January 28, 2021

Advocacy Groups Team Up to Fund World’s Largest JIA Register

News

Versus Arthritis and the British Society for Rheumatology have partnered to share data — and to fund the UK JIA Register, which will track the long-term safety and efficacy of ... Read more

December 3, 2020December 3, 2020

Free Online Booklet ‘My JIA’ Serves as Guide for Children, Families, and Schools

News

U.K. charity Juvenile Arthritis Research has published an informational booklet called “My JIA,” a resource for children with juvenile idiopathic arthritis (JIA), their families, caregivers, and schools. The booklet, available ... Read more

September 11, 2020September 11, 2020

Biologics as Initial sJIA Therapy Rising in US, But Glucocorticoids Still in Wide Use

News

Early treatment with biologics is increasingly being given to children newly diagnosed with systemic juvenile idiopathic arthritis (sJIA) in the U.S., but their use varies widely among hospitals and a reliance ... Read more

April 3, 2020April 3, 2020

Certain Vaccines in Children with Polyarticular JIA Maintain Effectiveness on Orencia, Study Finds

News

Young children with polyarticular juvenile idiopathic arthritis (pJIA) maintained effective vaccination against diphtheria and tetanus even after starting treatment with Orencia (abatecept) for up to two years, according to a ... Read more

March 10, 2020March 10, 2020

Stopping Ilaris Post-remission Is Feasible in Systemic JIA Children, Study Finds

News

Treatment with Ilaris (canakinumab) can be discontinued without relapse in some children with systemic juvenile arthritis (sJIA), according to a recent small study. Sustained remission specifically appears to be more ... Read more